Scarica l'app Stockscreener
1.44
1.37%
-0.02
Dopo l'orario di chiusura:
1.46
0.02
+1.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.46
Aprire:
$1.47
Volume 24 ore:
3.95M
Relative Volume:
1.54
Capitalizzazione di mercato:
$1.09B
Reddito:
$581.12M
Utile/perdita netta:
$-212.92M
Rapporto P/E:
-5.2593
EPS:
-0.2738
Flusso di cassa netto:
$-174.22M
1 W Prestazione:
-1.37%
1M Prestazione:
+27.43%
6M Prestazione:
+7.46%
1 anno Prestazione:
+5.11%
Intervallo 1D:
$1.43
$1.55
Intervallo di 1 settimana:
$1.37
$1.55
Portata 52W:
$0.9769
$1.60
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.44 | 1.10B | 581.12M | -212.92M | -174.22M | -0.2738 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-20 | Iniziato | JP Morgan | Neutral |
| 2025-10-31 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-25 | Iniziato | JP Morgan | Neutral |
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake - Insider Monkey
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN
OPK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Here's why you should retain OPK stock in your portfolio for now - MSN
OPKO Health Inc stock (US68375N1037): shares trade steady after recent earnings while valuation stay - AD HOC NEWS
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - Zacks Investment Research
OPKO Health stock (US68375N1037): earnings update keeps focus on pipeline and Rayaldee outlook - AD HOC NEWS
OPKO Health (OPK) price target increased by 11.18% to 3.86 - MSN
OPKO Health stock (US68375N1037): Company updates keep the biotech name in focus - AD HOC NEWS
Opko Health, Inc.Common Stock (NQ: OPK - FinancialContent
OPKO Health stock (US68375N1037): Genomics leader with recent subsidiary activity - AD HOC NEWS
ModeX to present preclinical CAR-T data at gene therapy meeting - Investing.com UK
OPKO Health’s ModeX Therapeutics Will Present Data - GlobeNewswire
Spotlight On Promising Penny Stocks For May 2026 - simplywall.st
OPK.O| Stock Price & Latest News - Reuters
Here's why you should hold OPK stock in your portfolio for now - msn.com
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
MSN Money - MSN
OPK Stock Price, Quote & Chart | OPKO HEALTH INC (NASDAQ:OPK) - ChartMill
OPKO Health, Inc. (NASDAQ:OPK) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
HC Wainwright Boosts Earnings Estimates for OPKO Health - MarketBeat
OPKO Health : Notice Annual Meeting of stockholders be held on Thursday, June 18, 2026. - marketscreener.com
OPKO gains 15% stake in Nicoya for China RAYALDEE rights - Investing.com UK
[ARS] OPKO HEALTH, INC. SEC Filing - Stock Titan
Board structure and pay detailed in OPKO Health (NASDAQ: OPK) 2026 proxy - Stock Titan
OPKO gains 15% stake in Nicoya for China RAYALDEE rights By Investing.com - Investing.com South Africa
OPKO Health receives 15% stake in Nicoya for China drug rights - StreetInsider
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China - marketscreener.com
Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright - MarketBeat
Order lab tests online or at home: BioReference opens new platform - Stock Titan
BioReference Launches BioReference Direct, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform - Moomoo
OPKO Health (OPK) reports Q1 loss, misses revenue estimates - MSN
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y - sharewise.com
OPKO Health Down Over 13%, On Pace for Largest Percent Decrease Since January 2024 -- Data Talk - Moomoo
OPKO Health (NASDAQ:OPK) Hits New 1-Year LowShould You Sell? - MarketBeat
This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
H.C. Wainwright reiterates Opko Health stock rating on Q1 results By Investing.com - Investing.com Australia
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.13%
2.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):